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Activating Fcγ receptors associated with Fc receptor γ-chain (FcRγ) are critical for
mediating neutrophil effector functions in immune complex-mediated autoimmune
diseases. FcRγ contains ITAM tyrosines and the in vivo role of these tyrosines has not
been defined in neutrophils and arthritis. In this study, the in vivo functions of FcRγ ITAM
tyrosines were characterized using wild type and ITAM tyrosine mutant (Y65F/Y76F)
transgenic mice crossed to an FcRγ-deficient genetic background. FcRγ-deficient
neutrophils showed undetectable cell surface expression of the activating Fcγ receptor
IV, defective immune complex-induced superoxide production, degranulation and
spreading. Although the re-expression of both the wild type and the ITAM tyrosine mutant
(Y65F/Y76F) FcRγ could restore activating Fcγ receptor expression of FcRγ-deficient
neutrophils, only the wild type transgenic form could mediate Fcγ receptor-dependent
effector functions. In contrast, neutrophils carrying ITAM tyrosine mutant FcRγ were
unable to produce superoxide, mediate degranulation and perform active spreading. In
addition, our results confirmed the protection of FcRγ-deficient mice from autoimmune
arthritis. Importantly, the presence of the wild type FcRγ transgene, in contrast to the
ITAM tyrosine mutant transgene, partially reversed autoimmune arthritis development.
The reversing effect of the wild type transgene was even more robust when animals
carried the wild type transgene in a homozygous form. Collectively, FcRγ ITAM tyrosines
play a critical role in the induction of neutrophil effector responses, the initiation and
progression of an autoantibody-induced experimental arthritis in vivo, indicating a
signaling, rather than just a receptor stabilizing function of the molecule.
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INTRODUCTION
Activating Fcγ receptors expressed on the surface of neutrophils are critical for mediating various
cellular responses including immune complex-triggered cellular activation, clearance of immune
complexes and phagocytosis of opsonized particles (1–3). These processes are involved in the
pathogenesis of various autoimmune diseases including rheumatoid arthritis (2–4).
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Resting human neutrophils express the activating Fcγ
receptors FcγRIIA and FcγRIIIB, while FcγRI appears upon
stimulation (5). While the single chain transmembrane FcγRIIA
contains an immunoreceptor tyrosine-based activation motif
(ITAM) in the cytoplasmic tail of the molecule, FcγRI is
associated with an ITAM-bearing transmembrane adapter
protein called Fc receptor γ-chain (FcRγ). In addition, the GPI-
anchored FcγRIIIB is also present on the surface of human
neutrophils. This molecule does not contain an ITAM-motif
and is not associated with an ITAM-bearing adapter side chain;
according to the current view it is functionally connected to
FcγRIIA (5, 6).
Murine neutrophils express a different set of activating Fc
receptors including two low affinity (FcγRIII and FcγRIV)
and one high affinity (FcγRI) Fcγ receptors, all of which are
associated with the ITAM-containing FcRγ (5). Our previous
findings indicated the critical but overlapping role of FcγRIII and
FcγRIV in immune complex-dependent neutrophil activation
(6). Subsequent in vivo studies revealed the importance of
FcγRIII and FcγRIV for the development and progression
of autoantibody-induced arthritis and autoimmune valvular
carditis in the K/BxN serum transfer experimental model (7, 8).
As discussed above, all activating murine Fcγ receptors form
a complex with FcRγ, which molecule does not contain a ligand
binding domain (1). It is known that the lack of FcRγ abrogates
the cell surface expression of activating Fcγ receptors and FcRγ-
deficiency leads to abolished Fc receptor-dependent neutrophil
effector responses and protection from autoimmune arthritis (6,
9–13). However, due to the absence of the cell surface expression
of activating Fcγ receptors in FcRγ-deficient mice, it remains
unclear whether the sole function of FcRγ is to enable the
receptor expression or it is also actively involved in the signaling
process through its ITAM tyrosines.
In prior in vitro structure-function studies, the role of
ITAM tyrosine phosphorylation was demonstrated in serotonin
secretion in a basophilic cell line suggesting the signaling
function of FcRγ ITAM tyrosines (14). It was also reported that
the phosphorylation of the ITAM tyrosines is induced by the
FcRγ-associated FcεR stimulation in mast cells (15).
The functional role of these ITAM tyrosines was characterized
using FcRγ-deficient mice reconstituted with murine wild type
and ITAM tyrosine mutant (Y65F/Y76F) transgenes. These
findings suggested that the ITAM tyrosines are involved in
degranulation, cytokine production, prostaglandin synthesis and
passive systemic anaphylaxis inmast cells (16). In another genetic
model for in vivo studies, human transgenic FcRγ was expressed
carrying mutated ITAM tyrosines on an FcRγ-deficient genetic
background (NOTAM mice) (17). While the surface expression
of Fc receptors was not affected, the in vivo cytotoxicity critically
depended on FcRγ ITAM signaling (17). The uptake of immune
complexes and the cross presentation of antigens was reported
to be regulated by FcRγ ITAM signaling in dendritic cells, while
Abbreviations: FcRγ, Fc receptor γ-chain; IC, Immune complex; ITAM,
Immunoreceptor tyrosine-based activation motif; FcR, Fc receptor; GPI,
Glycosylphosphatidylinositol; PCR, Polymerase chain reaction; PMA, Phorbol
myristate acetate; WT, Wild type.
MHC class II antigen presentation was ITAM-independent (18).
In contrast to the first two reports suggesting the functions
of FcRγ ITAM tyrosines, recent mouse studies revealed that
daratumumab, which is a monoclonal therapeutic antibody
targeting CD38 that is highly expressed on the surface of some
kinds of tumor cells, induces cancer cell death after its binding,
which process occurs in NOTAM but not in FcRγ-deficient mice
after blocking FcγRIIB (19). In addition, Lehmann et al. showed
that engineered chimeric antibodies instructed splenic dendritic
cells to activate CD4- and CD8-positive T-cells through the FcRγ-
coupled FcγRIV without the involvement of the ITAM tyrosines
(20). Collectively, these recent reports indicated the existence of
ITAM-independent in vivo functions of FcRγ-coupled activating
Fc receptors (19, 20). Therefore, further studies are needed to
define the in vivo role of FcRγ ITAM tyrosines.
Upon Fc receptor-stimulation of neutrophils, FcRγ was
reported to be phosphorylated and to recruit the Syk tyrosine
kinase, which promotes activation of the distal signaling
pathways and induces cellular effector responses (6, 21, 22).
However, the functional role of the FcRγ ITAM tyrosines has
not been directly tested in neutrophils and neutrophil-dependent
autoimmune diseases in vivo. Herein, we used a genetic approach
to characterize the possible role of FcRγ ITAM tyrosines in
neutrophils and in vivo autoimmune arthritis. We demonstrated
that FcRγ ITAM tyrosines are required for the immune complex-
dependent activation of neutrophils and the development and
progression of experimental autoimmune arthritis.
MATERIALS AND METHODS
Animals
FcRγ-deficient (Fcer1gtm1Rav/tm1Rav, referred to as FcRγ KO)
mice were purchased from Taconic Farms (Hudson, NY, USA)
(10). Animals expressing the wild type and the ITAM tyrosine
mutant FcRγ (where tyrosines at positions 65 and 76 were
replaced by phenylalanines) were described previously and were
crossed with FcRγ KO mice (referred to as FcRγ KO + WT
FcRγ Tg and FcRγ KO + YF FcRγ Tg animals, respectively)
(16). To augment the expression of the transgenic wild type
and mutant FcRγ chain, the mice were crossed to obtain
homozygous, double transgenic animals (referred to as FcRγ
KO + 2x WT FcRγ Tg and FcRγ KO + 2x YF FcRγ Tg
mice, respectively). Single and double transgenic animals were
differentiated by quantitative PCR. Mice carrying the KRN T-
cell-receptor transgene were maintained in heterozygous form
by mating with C57BL/6 mice (23). All transgenic mice were
backcrossed to the C57BL/6 genetic background. Genotyping was
performed by allele-specific PCR.
Wild type control C57BL/6 mice were purchased from
Charles River or the Hungarian National Institute of Oncology
(Budapest, Hungary). NOD mice, as well as a congenic strain
carrying the CD45.1 allele on the C57BL/6 genetic background
(B6.SJL-Ptprca) were purchased from the Jackson Laboratory.
Mice were kept in individually ventilated cages (Tecniplast)
in a conventional facility. All animal experiments were
approved by the Animal Experimentation Review Board of the
Semmelweis University.
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Bone marrow chimeras were generated by intravenous
injection of unfractionated bone marrow cells into recipients
carrying the CD45.1 allele on the C57BL/6 genetic background,
which were lethally irradiated before by 11Gy from a 137Cs
source using a Gamma-Service Medical (Leipzig, Germany)
D1 irradiator. 4 weeks after transplantation, peripheral blood
samples were stained for Ly6G and CD45.2 (Clones 1A8 and
104, respectively; both from BD Biosciences) and analyzed by
a BD Biosciences FACSCalibur flow cytometer as previously
described (21).
K/B×N Serum-Transfer Arthritis
Mice carrying the KRN T-cell receptor transgene on the C57BL/6
genetic background were mated with NOD mice to obtain
transgene-positive (arthritic) K/B×N and transgene-negative
(control) B×N mice (23, 24). The presence of the transgene was
determined by allele-specific PCR and confirmed by phenotypic
assessment. Blood was taken by retroorbital bleeding and sera
from arthritic and control mice were pooled separately.
Arthritis was induced by a single intraperitoneal injection of
400 µl K/B×N (arthritic) or B×N (control) serum into intact
mice or bone marrow chimeras, followed by daily assessment of
arthritis severity for 2 weeks as described (24–26). Visible clinical
signs were scored on a 0–10 scale by two investigators blinded
for the origin and treatment of the mice. Ankle thickness was
measured by a spring-loaded caliper (Kroeplin). For histological
analysis, mice were sacrificed on Day 8, their fore limbs were
fixed in 4% paraformaldehyde, decalcified (Osteomoll, Merck
Millipore) dehydrated, embedded in paraffin, sectioned at 9 µm
thickness and stained with hematoxylin and eosin.
Isolation and Activation of Neutrophils
Mouse neutrophils were isolated from the bone marrow of
the femurs and tibias of intact mice or chimeras by hypotonic
lysis followed by Percoll (GE Healthcare) gradient centrifugation
using sterile and endotoxin-free reagents as described (25–27).
Cell surface FcγRIV expression was detected by an anti-FcγRIV
antibody (Clone 9E9; a gift from Prof. Jeffrey V. Ravetch).
A secondary staining with FITC labeled anti-Armenian and
Syrian hamster antibodies (Clones G70-204 and G94-56; BD
Biosciences) was performed.
Neutrophils were kept at room temperature in Ca2+-
and Mg2+-free medium until use and prewarmed to 37◦C
prior to activation. Neutrophil assays were performed at
37◦C in HBSS supplemented with 20mM HEPES, pH 7.4.
To obtain immobilized immune complex-coated surfaces,
human lactoferrin (LFR; Sigma-Aldrich) was either bound
directly to regular Nunc MaxiSorp F96 (Thermo Fisher) plates
(for superoxide release and degranulation measurements) or
covalently linked to poly-L-lysine-coated 24-well tissue culture
plates (for spreading assays) and then treated with rabbit anti-
LFR IgG (Sigma-Aldrich) as described (6). Superoxide release
by neutrophils was followed by a cytochrome c reduction
test from 100 µl aliquots of 4 × 106/ml cells plated on
immobilized immune complexes or on 10% fetal cow serum
(FCS) in the presence of PMA as described (25). The release
of gelatinase was determined by gelatinase zymography as
previously described (6). Spreading of the cells was followed by
phase contrast microscopy.
Biochemical Studies
For analysis of protein contents, neutrophils were lysed in
100mM NaCl, 30mM Na-HEPES (pH 7.4), 20mM NaF,
1mM Na-EGTA, 1% Triton X-100, 1mM benzamidine, freshly
supplemented with 0.1 U/ml Aprotinin, 1:100 Mammalian
Protease Inhibitor Cocktail, 1:100 Phosphatase Inhibitor Cocktail
2, 1mM PMSF and 1mM Na3VO4 (all from Sigma-Aldrich).
After removal of insoluble material, lysates were boiled in
sample buffer. Whole cell lysates were run on SDS-PAGE and
immunoblotted using antibodies against FcRγ (Host: rabbit;
Upstate) or β-actin (Clone AC-74; Sigma-Aldrich) and by
peroxidase-labeled secondary antibodies (GE Healthcare). The
signal was developed using the ECL system (GE Healthcare) and
exposed to X-ray films.
Presentation of the Data and Statistical
Analysis
Experiments were performed the indicated number of times.
Quantitative graphs and kinetic curves showmean and SEM from
all independent in vitro experiments or from all individual mice
from the indicated number of experiments. Statistical analyses
were carried out by the STATISTICA software using two-way
(factorial) ANOVA, with treatment and genotype being the two
independent variables. In case of kinetic assays, area under the
curve (AUC) was used for statistical analysis. P values below 0.05
were considered statistically significant.
RESULTS
FcRγ-Deficient Neutrophils Have Impaired
Immune Complex-Mediated Cell
Responses and Lack Activating Fc
Receptors From the Cell Surface
First, we characterized the phenotype of the FcRγ-deficient
neutrophils. When plating on immobilized immune complex
surfaces, freshly isolated wild type mouse neutrophils were able
to produce superoxide, while in the absence of the FcRγ the
cell response was abolished (Figure 1A; P = 1.3 × 10−4). In
line with this finding, FcRγ-deficient neutrophils were unable to
release the granule marker gelatinase or perform cell spreading
(Figures 1B,C; P = 2.6 × 10−4 and P = 1.4 × 10−4).
Meanwhile, the absence of the adaptor chain did not affect Fc
receptor-independent superoxide production triggered by PMA
compared to wild type cells (Figure 1D; P = 0.81). However,
the activating, FcRγ-associated Fcγ receptor IV was found to
be absent from the cell surface of FcRγ-deficient neutrophils
(Figure 1E; P = 4.4× 10−5).
Restoration of FcRγ-Expression in
Neutrophils by Wild Type and ITAM Mutant
FcRγ
For investigating the role of the intracellular ITAM tyrosines
in various cell responses, we re-expressed wild type or ITAM
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FIGURE 1 | Impaired effector responses and activating Fc receptor-expression in FcRγ-deficient neutrophils. Wild type (WT) and FcRγ-deficient (FcRγ KO) neutrophils
were plated on immobilized immune complexes and their superoxide release (A), gelatinase degranulation (B), and spreading (C) was followed. The ability of FcRγ KO
cells to produce superoxide anions was tested by PMA stimulation (at a 100 nM concentration) (D). Neutrophil cell surface FcγRIV expression was detected by flow
cytometry (E). The gelatinase zymogram, the photos and the flow cytometric curves are representative of 3–7 independent experiments. Kinetic curves in (A,D) show
mean and SEM of 3 independent experiments. Control data points were subtracted. See the text for actual P values. IC, Immune complex; PMA, Phorbol myristate
acetate.
tyrosine mutant FcRγ in mice on an FcRγ-deficient background.
According to the immunoblot results, neutrophils from the wild
type and the ITAM tyrosine mutant FcRγ transgenic mice could
produce the protein (Figure 2A; the expression level was 24% and
68% of the original wild type level, respectively; P = 2.2× 10−3
for FcRγ KO + WT FcRγ Tg vs. FcRγ KO). As a consequence,
the activating Fcγ receptor IV appeared on the cell surface of the
two different transgenic neutrophil populations (Figure 2B; the
expression level was 25 and 43% of the maximum, respectively;
P = 0.026 for FcRγ KO + WT FcRγ Tg vs. FcRγ KO). We
further analyzed the neutrophil counts in the periphery or in
the bone marrow in wild type, FcRγ-deficient, wild type and
ITAM mutant FcRγ-expressing mice and we did not detect
significant differences in the sizes of the granulocyte populations
(Figures 2C,D; P = 0.09 and P = 0.97, respectively). This
indicated that transgenic re-expression of wild type and ITAM
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FIGURE 2 | Restoration of (cell surface) expression of FcRγ in neutrophils by wild type and ITAM mutant FcRγ transgenes on an FcRγ-deficient background. FcRγ
expression was tested by immunoblotting on whole cell lysates of wild type (WT), FcRγ-deficient (FcRγ KO), wild type FcRγ transgenic (FcRγ KO + WT FcRγ Tg) or
ITAM tyrosine mutant FcRγ transgenic (FcRγ KO + YF FcRγ Tg) neutrophils (A). Cell surface expression of the activating receptor FcγRIV was followed by flow
cytometry (B). The blot and the flow cytometric curves are representative of 6–7 independent experiments. The circulating neutrophil (PMN) counts are presented in
wild type (WT), FcRγ-deficient (FcRγ KO), wild type FcRγ transgenic (FcRγ KO + WT FcRγ Tg) or ITAM tyrosine mutant FcRγ (FcRγ KO + YF FcRγ Tg) neutrophils
(C). The average bone marrow-isolated neutrophil numbers did not differ significantly in the different genotypes (D). (C,D) Show mean and SEM from 2 to 11
independent experiments. See the text for actual P values. PMN, Polymorphonuclear cells (neutrophils).
tyrosine mutant FcRγ did not interfere with neutrophil survival
and viability.
FcRγ ITAM Tyrosines Are Critical for
Immune Complex-Mediated Neutrophil
Cell Responses
Compared to FcRγ-deficient neutrophils, re-expression of the
wild type FcRγ could partially restore the Fc receptor-mediated
release of superoxide, while this response was totally blocked
in connection with ITAM tyrosine mutant FcRγ-bearing cells
(Figure 3A; P = 0.017 for FcRγ KO + WT FcRγ Tg vs. FcRγ
KO + YF FcRγ Tg and P = 0.75 for FcRγ KO + YF FcRγ
Tg vs. FcRγ KO). The same essential role of these tyrosines
could be observed in connection with gelatinase degranulation
and cell spreading (Figures 3B,C; P = 0.04 for FcRγ KO +WT
FcRγ Tg vs. FcRγ KO + YF FcRγ Tg and P = 0.02 for FcRγ
KO + WT FcRγ Tg vs. FcRγ KO + YF FcRγ Tg, respectively).
In contrast to immune complex-triggered conditions, PMA
induced a robust superoxide production in all genotypes
(Figure 3D; P = 0.90).
Essential Role of FcRγ ITAM Tyrosines in
Arthritis Development
For the in vivo studies, besides using intact mice, we also
generated bone marrow, radiation chimeras in order to
investigate the role of the FcRγ ITAM tyrosines in the myeloid
compartment. In general, we did not see substantial differences
between the arthritic phenotypes of the intact animals and the
bone marrow chimeras. When receiving K/BxN serum, a small,
but significant visible inflammation appeared on the fore and
hind limbs of the wild type FcRγ transgenic mice that was
totally missing from the animals with the ITAM mutant FcRγ
(Figures 4A,B; P = 0.034 for FcRγ KO +WT FcRγ Tg vs. FcRγ
KO + YF FcRγ Tg and P = 0.61 for FcRγ KO + YF FcRγ Tg vs.
FcRγ KO in connection with the fore limbs; P = 0.012 for FcRγ
KO + WT FcRγ Tg vs. FcRγ KO + YF FcRγ Tg and P = 0.87
for FcRγ KO + YF FcRγ Tg vs. FcRγ KO in connection with
the hind limbs). However, we could not detect ankle thickness
changes in the wild type FcRγ transgenic mice despite of a
massive leukocyte infiltration to the joints seen on the histological
sections in contrast to ITAM tyrosine mutant FcRγ expressing
animals (Figures 4C,D; P = 0.27 for FcRγ KO + WT FcRγ Tg
vs. FcRγ KO in Panel C).
Augmentation of the Expression of the
Transgenic Wild Type but not the ITAM
Mutant FcRγ Enhances Arthritis Severity
For raising the expression level of the wild type and ITAM
mutant transgenic FcRγ, we crossed the single transgenic
(hemizygous) mice to obtain double transgenic (homozygous)
animals. As shown in Figure 5A, this process resulted in an
obvious enhancement in the levels of FcRγ in neutrophils of the
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FIGURE 3 | Critical role of the intracellular FcRγ ITAM tyrosines in mediating neutrophil cell responses in vitro. Wild type (WT), FcRγ-deficient (FcRγ KO), wild type
FcRγ transgenic (FcRγ KO + WT FcRγ Tg) or ITAM tyrosine mutant FcRγ transgenic (FcRγ KO + YF FcRγ Tg) neutrophils were plated on immobilized immune
complex surfaces and their superoxide release (A), gelatinase release (B) and cell spreading (C) was detected. The functionality of all genotypes was tested by PMA
stimulation (D). Kinetic curves in (A,D) represent mean and SEM from 3 independent experiments. The gelatinase zymogram and the photos are representative of 3
independent experiments. See the text for actual P values. IC, Immune complex; PMA, Phorbol myristate acetate.
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FIGURE 4 | Re-expression of the wild type but not the ITAM tyrosine mutant FcRγ transgene partially reverses the arthritic phenotype. Wild type (WT), FcRγ-deficient
(FcRγ KO), wild type FcRγ transgenic (FcRγ KO + WT FcRγ Tg) or ITAM tyrosine mutant FcRγ transgenic (FcRγ KO + YF FcRγ Tg) animals were injected with B×N
(Control) or K/B×N (Arthritic) serum intraperitonally on Day 0. Arthritis development was followed by clinical scoring of the fore limbs (A) and the hind limbs (B) and
ankle thickness measurement (C). Leukocyte infiltration was visualized by microscopy after hematoxylin and eosin staining [(D), 20x original magnification, bars:
100 µm; asterisks point at infiltrating leukocytes]. Quantitative data show mean and SEM from 6 to 7 control and 6 to 7 arthritic serum-treated individual mice per
group from 3 independent experiments (A–C). See the text for actual P values.
homozygous transgenicmice compared to that of the hemizygous
ones. The augmentation also appeared in the changes of the
cell surface Fcγ receptor IV-expression (Figure 5B). Double
transgenic wild type FcRγ bone marrow chimeras showed
a robust arthritic phenotype on all limbs, while the double
transgenic ITAM tyrosine mutant FcRγ chimeras were totally
protected from arthritis development (Figures 5C,D; P = 0.04
for FcRγ KO + 2x WT FcRγ Tg vs. FcRγ KO + 2x YF
FcRγ Tg and P = 0.70 for FcRγ KO + 2x YF FcRγ Tg vs.
FcRγ KO in connection with the fore limbs; P = 9.2 × 10−3
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FIGURE 5 | Dose-dependent effect of the wild type transgene on the severity of autoimmune arthritis in contrast to complete protection of the ITAM tyrosine mutant
animals. FcRγ expression was tested by immunoblotting on whole cell lysates of neutrophils (A), while cell surface expression of the FcγRIV was followed by flow
cytometry (B). (C–E) Wild type (WT), FcRγ-deficient (FcRγ KO), double wild type FcRγ transgenic (FcRγ KO + 2x WT FcRγ Tg) or double ITAM tyrosine mutant FcRγ
transgenic (FcRγ KO + 2x YF FcRγ Tg) bone marrow chimeras were injected with B×N (Control) or K/B×N (Arthritic) serum intraperitonally on Day 0. Arthritis
development was followed by clinical scoring of the fore limbs (C) and the hind limbs (D) and ankle thickness measurement (E). The blot and the flow cytometric
curves are representative of 4 independent experiments. Quantitative data show mean and SEM from 4 to 5 control and 5 to 6 arthritic serum-treated individual mice
per group from 2 independent experiments (C–E). See the text for actual P values.
for FcRγ KO + 2x WT FcRγ Tg vs. FcRγ KO + 2x YF
FcRγ Tg and P = 0.96 for FcRγ KO + 2x YF FcRγ Tg vs.
FcRγ KO in connection with the hind limbs). Double wild
type FcRγ transgenic bone marrow chimeras also showed a
significant ankle thickening compared to the homozygous ITAM
mutant FcRγ transgenic bone marrow chimeras (Figure 5E; P
= 0.01 for FcRγ KO + 2x WT FcRγ Tg vs. FcRγ KO + 2x
YF FcRγ Tg and P = 0.96 for FcRγ KO + 2x YF FcRγ Tg
vs. FcRγ KO).
Our results indicate an essential role for the FcRγ ITAM
tyrosines in immune complex-triggered neutrophil cell responses
and experimental arthritis.
DISCUSSION
Our results show that FcRγ is critical to stabilize the expression of
the activating Fcγ receptors in the plasma membrane and reveals
that this function is independent from the presence of its ITAM
tyrosines (Figure 2). Former in vitro studies demonstrated the
importance of a non-covalent, salt bridge-mediated interaction
between the Fcγ receptor and the ITAM-containing side chain
in the endoplasmic reticulum to prevent the degradation of the
complex and enable the transfer of the complex to the Golgi
apparatus (28). It is thought that this process is involved in
the regulation of the cell surface expression of Fcγ receptors.
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Although our findings fit into this picture, further studies will
be needed to characterize the intracellular mechanisms which
stabilize and prevent the complex from degradation.
As a key observation, our structure-function studies revealed
the importance of FcRγ ITAM tyrosines in immune complex-
mediated neutrophil effector functions including the release of
reactive oxygen species, degranulation and spreading. These
findings are in accordance with previous studies of basophilic cell
lines, in which the role of ITAM tyrosines was shown in FcγRIIA
signaling, and in mast cells, where cell functions were abrogated
after IgE-dependent stimulation (14, 16).
In vivo studies using murine wild type and ITAM tyrosine
mutant transgenes suggested that the ITAM tyrosines are
involved in degranulation, cytokine production, prostaglandin
synthesis, and passive systemic anaphylaxis in mast cells (16).
Even though the early in vivo studies on the NOTAM mouse
carrying ITAM mutant FcRγ indicated the ITAM-dependence
of in vivo cytotoxicity, uptake of immune complexes, and
the cross presentation of antigens in dendritic cells (17, 18),
recent papers revealed that daratumumab-induced cancer cell
death (after blocking FcγRIIB) and the splenic dendritic cell-
mediated activation of CD4- and CD8-positive T cells occur
in an FcRγ ITAM-independent manner (19, 20). In connection
to this, our in vivo studies indicate that FcRγ ITAM signaling
is essential for mediating the initiation and progression of
autoimmune arthritis. However, further studies are needed to
test whether—similarly to dendritic cells—ITAM independent
signaling mechanisms are also involved in other in vivo functions
of neutrophils. It would be also informative to test the role of
the ITAM tyrosines of FcRγ in other autoantibody-mediated
disease models in the future to further support our findings with
experimental arthritis.
In vitro and in vivo studies monitoring the phosphorylation
state of ITAM tyrosines indicated that both ITAM tyrosines
are phosphorylated upon stimulation, but the carboxy-terminal
tends to be dephosphorylated much faster in mast cells (15).
However, it is not known how the phosphorylation state of the
two tyrosines is regulated in neutrophils.
It should be noted that not only FcγRIII and FcγRIV—
the receptor that is alone sufficient to induce arthritis
(7)—, but other receptors also are associated with FcRγ,
including Paired Immunglobulin-like receptor-A (PIR-
A), Leukocyte immunglobulin-like receptor 1C (LILR1C),
Osteoclast-associated receptor (OSCAR), T cell-interacting,
activating receptor on myeloid cells-1 (TARM1), Dectin-2
or some β integrins in neutrophils (29–36). Further studies
are needed whether the ligand binding or crosslinking
of these receptors require the function of the FcRγ
ITAM tyrosines to enable the expression and induction of
cellular responses.
As shown in Figures 2 and 5, the expression levels of the
wild type and the FcRγ ITAM mutant transgenic neutrophils
are different. The presence of the complex between the
ITAM-containing molecule and the Fcγ receptor has been
reported in the endoplasmic reticulum, which is likely the
cellular organism where the stability of the complex and
the degradation of the components is actively regulated that
may require the presence of the ITAM tyrosines (28). It is
also possible that the copy numbers of the two transgenes
are different. A third possibility is that different enhancer
and silencer elements are involved in the regulation of
the expression of the two transgenes as they may not be
present at the same place in the genome. Most importantly,
despite of the higher level, ITAM mutant FcRγ was not
able to restore neutrophil effector responses and reverse the
development of autoimmune arthritis, which further support
our conclusions.
Compared to the hemizygous animals, the double transgenic
wild type FcRγ mice could reverse more effectively the
development of autoimmune arthritis on the FcRγ-deficient
background, indicating that the disease progression is highly
dependent on the level of the signaling molecule. This can be
the explanation of why the ankle thickness was not significantly
changed, while the increase in the more sensitive clinical score
was significant and the immune cell infiltration was massive and
robust in the single wild type FcRγ ITAM transgenic animals.
As the absence of FcRγ was not required for neutrophil
migration in experimental arthritis, it can be hypothesized that
FcRγ ITAM tyrosines are also not involved in the accumulation
of neutrophils at the site of inflammation (37). These tyrosines
could rather have a role in mediating immune complex-triggered
responses at the site of tissue damage as we showed it in
connection with several other molecules involved in neutrophil
Fcγ receptor signaling (21, 24, 26).
Besides neutrophils, other cell types like macrophages, mast
cells or platelets have been indicated in the pathogenesis of
experimental arthritis (38–41). It would be interesting to test the
role of the ITAM tyrosines of FcRγ in these cell populations in
joint inflammation. Collectively, our studies revealed the critical
role of FcRγ ITAM tyrosines in immune complex-mediated
activation of neutrophils and the development and progression
of autoantibody-induced autoimmune arthritis. Importantly, our
studies provide the first direct in vivo evidence for the role of
FcRγ ITAM tyrosines in a neutrophil-dependent in vivo arthritis
model. Understanding these molecular mechanisms can serve as
new therapeutic targets in the treatment of some autoimmune
diseases in the future (e.g., by the development of molecules
which may mask the ITAM tyrosines of FcRγ).
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